Answer
No. It is an immunotherapy that blocks the PD-1 immune checkpoint. For some lung cancers it is licensed alongside platinum-based chemotherapy.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion. — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.